Search Results 1161-1170 of 17169 for Green Birth Control

1. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

   Male and female patients ≥ 18 years of age from the date of birth. ... Control of the disorder with replacement therapy ... In case of use of oral contraception, ...

2. Cancer Treatment! Clinical Trials - Mayo Clinic Research

   ... population undergoing cytotoxic chemotherapy. A ... The Enhanced, EHR-facilitated Cancer Symptom Control ... management education, and 3) suggesting ...

3. A Study to Evaluate the Correlation Between Aging and Bleeding in von Willebrand disease - Mayo Clinic

   ... population. In order to discover this, the study will examine medical history, blood and genetic tests for VWD and bleeding and collect information about ...

4. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study ...

5. A Study to Understand How the Inner Ear Balance Works and Develop a Tool to help Identify Inner Ear Balance Disorders - Mayo Clinic

   Control subjects: Must have no history of complaints of dizziness or imbalance and normal responses on ocular motor, positional, caloric and sinusoidal ...

6. Clinical trials - Oncology (Medical)

   The purpose of this multicenter prospective observational case-control study is to train and validate Adela's cfMeDIP-seq based methylome profiling platform to ...

7. Clinical trials - Oncology (Medical)

   A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

8. Pediatrics Clinical Trials - Medical Professionals

   albicans in the microbial communities of a population of children at-risk for atopic dermatitis compared to healthy controls who do not have an underlying risk ...

9. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

   ... birth control until 28 days following the last dose of the study drug, and females must agree to not breastfeed during the study 13. Written informed ...

10. A Study to Evaluate Post-discharge Early Assessment with a Video Visit - Mayo Clinic

    Participants in each arm will participate in a telephone survey 4-6 days after hospital discharge reviewing discharge medication and self-management.